| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 152-53-4 | cycloguanil hydrochloride | 熔点：210-215°C
|
C11H15Cl2N5 | 288.18 |
| 152-47-6 | n(sup 1)-(3-methoxypyrazinyl)-sulfanilamid | 熔点：176-180°C
|
C11H12N4O3S | 280.3 |
| 152-43-2 | quinestriol | 密度：1.15 g/cm3
熔点：107 - 108ºC
沸点：502.5ºC
|
C25H32O2 | 364.52 |
| 152-25-0 | (oxalylbis(iminoethylene))bis(benzyldiethyl-ammoniu dichloride | |
| |
| 152-24-9 | (oxalylbis(iminotrimethylene))bis((o-chlorobenzyl)diethyl-ammoniu dichlorid | |
| |
| 152-23-8 | (oxalylbis(iminoethylene))bis(diethyl(o-methoxybenzyl)-ammoniu dichloride | |
| |
| 152-22-7 | (2-hydroxyethyl)triethyl-ammoniu chloride | |
C8H20ClNO | 181.7035 |
| 152-20-5 | thiophosphoric acid O,O',S-trimethyl ester | 密度：1.25 g/cm3
|
C3H9O3PS | 156.14 |
| 152-18-1 | phosphorothioic acid, o,o,o-trimethyl ester | |
| |
| 152-16-9 | octamethyl-pyrophosphoramid | |
C8H24N4O3P2 | 286.25 |
| 152-11-4 | 盐酸维拉帕米
5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-valeronitril | 熔点：140-144℃
|
C27H39ClN2O4 | 491.07 |
| 152-02-3 | (-)-morphinan-3-o | |
| |
| 15199-43-6 | dimethyl-d6 sulfate | 密度：1.39
沸点：60-61℃(7
|
[2H]6C2O4S | 132.16 |
| 15199-41-4 | cyclododecanediol | |
C12H24O2 | 200.32 |
| 15199-26-5 | 2-((4-methylphenyl)thio)-1h-isoindole-3(2h)-dione | |
| |
| 151982-51-3 | 4-bromo-2-fluorobenzoyl chloride | |
C7H3BrClFO | 237.45 |
| 15196-73-3 | 4-tert-butylbenzo-15-crown-5 | 密度：1.020±0.06 g/cm3(Predicted)
熔点：92-95 °C
沸点：436.5±45.0 °C(Predicted)
|
C18H28O5 | 324.41 |
| 15196-51-7 | octadecanoic acid, 2,2-dimethyl-1,3-propanediyl ester | |
| |
| 15196-10-8 | succinyldithiocholine | |
| |
| 151957-36-7 | n-(alpha)fluorenylmethoxycarbonyl-glutamyl-glutamyl-phosphotyrosyl-alanyl-alani | |
| |
| 151957-35-6 | glutamyl-glutamyl-phosphotyrosyl-alanyl-alanine | |
| |
| 151956-14-8 | 2,4-thiazolidinedione, 3-(2-(4-chlorophenyl)-2-oxoethyl)-5-((4-methylphenyl)met | |
| |
| 151956-13-7 | 2,4-thiazolidinedione, 3-(2-(4-chlorophenyl)-2-oxoethyl)-5-((4-fluorophenyl)met | |
| |
| 151956-10-4 | 2,4-thiazolidinedione, 5-((2-chlorophenyl)methylene)-3-(2-(4-chlorophenyl)-2-ox | |
| |
| 151956-07-9 | 2,4-thiazolidinedione, 5-((4-chlorophenyl)methylene)-3-(2-(4-fluorophenyl)-2-ox | |
| |
| 151956-06-8 | 2,4-thiazolidinedione, 5-((2-chlorophenyl)methylene)-3-(2-(4-fluorophenyl)-2-ox | |
| |
| 151956-05-7 | 5-((3-fluorophenyl)methylene)-3-(2-oxo-2-phenylethyl)-4-thiazolidinedione | |
| |
| 15195-92-3 | alpha-(1-methyl-2-(1-pyrrolidinyl)ethyl)-, hydrochloride, (d)-benzhydro | |
| |
| 15195-90-1 | alpha,alpha-diphenyl-beta-methyl-, hydrochloride, l-1-pyrrolidinepropano | |
| |
| 15195-06-9 | strontium bis(dioxoarsenate) | |
| |
| 15195-00-3 | arsenic acid, calcium salt (1:1) | |
| |
| 15194-98-6 | arsenenous acid, calcium salt (2:1) | |
| |
| 15193-51-8 | 5-methoxy-2-benzothiazolinon | |
C8H7NO2S | 181.21 |
| 151922-17-7 | 6-demethyl-9-(n,n-dimethylglycylamido)-6-deoxytetracycline | |
| |
| 151922-16-6 | 9-(n,n-dimethylglycylamido)minocycline | |
| |
| 151921-21-0 | 2-amino-n-(2,3-dihydro-1,5-methyl-3-oxo-2-phenyl-1h-pyrazol-4-yl)-acetamid | |
| |
| 151921-20-9 | propanamide, 2-amino-n-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1h-pyrazol-4-yl | |
| |
| 151921-19-6 | benzenepropanamide, alpha-(benzoylamino)-n-(2,3-dihydro-1,5-dimethyl-3-oxo-2-ph | |
| |
| 151921-18-5 | 1- dimethyl-2-oxoethyl)-)- | |
| |
| 151921-17-4 | benzamide, n-(2-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1h-pyrazol-4-yl)amino | |
| |
| 151921-16-3 | 4,6(1h,5h)-pyrimidinedione, dihydro-1-(3-chloro-2-oxo-4-(2-phenylethenyl)-1-aze | |
| |
| 151921-15-2 | 4,6(1h,5h)-pyrimidinedione, dihydro-1-(3-chloro-2-(2-chlorophenyl)-4-oxo-1-azet | |
| |
| 151921-14-1 | 5h)-pyrimidinedione, dihydro-1-(3-chloro-2-oxo-4-phenyl-1-azetidinyl)-3-6(1h | |
| |
| 151921-13-0 | l-1h-pyrazol-4-yl)amino )acetyl)-3-((2-furanylmethylene)amino)-2-thioxo- | |
| |
| 151921-12-9 | l-1h-pyrazol-4-yl)amino )acetyl)-3-((3-phenyl-2-propenylidene)amino)-2-thioxo- | |
| |
| 151921-11-8 | 4,6(1h,5h)-pyrimidinedione, dihydro-1-(((2-chlorophenyl)methylene)amino)-3-(((2 | |
| |
| 151921-10-7 | 4,6(1h,5h)-pyrimidinedione, dihydro-1-(((2,3-dihydro-1,5-dimethyl-3-oxo-2-pheny | |
| |
| 15192-52-6 | alpha,alpha-diphenyl-beta-methyl-1-pyrrolidinepropano hydrochloride | |
| |
| 151915-04-7 | n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine | |
| |
| 151912-49-1 | cacn protein | |
| |
